• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用分次放射治疗与化疗联合方案控制局部肿瘤生长。

Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens.

作者信息

Poulakos L, Schenken L L, Hagemann R F, Burholt D R, Lesher S

出版信息

J Natl Cancer Inst. 1975 May;54(5):1103-5. doi: 10.1093/jnci/54.5.1103.

DOI:10.1093/jnci/54.5.1103
PMID:805253
Abstract

A treatment concept for the control of tumor growth utilized weekday radiotherapy and weekend chemotherapy. Mice were given sc injections of P815X2 mastocytoma cells on the lower back (day 0) and separated into the following treatment groups: 5-day/week X-irradiation, adriamycin alone at either 5 mg/kg body wt (days 6 and 13) or 2 mg/kg (days 5, 12, and 19), and combined radiotherapy and chemotherapy. Untreated controls had a mean tumor volume of 2.77 cm-3 and a mean survival time of 24 days. Adriamycin alone at 5 mg/kg resulted in an eventual tumor of 70 percent of the control value at death, whereas at 2mg/kg the tumor volume was 60 percent of control. After radiotherapy only, tumor size was 52 percent of control. Irradiation plus either 5 or 2 mg drug per kg body wt resulted in tumor volumes of 23 and 30 percent, respectively, of control values. Although no treatment regimen prolonged survival, the marked reduction in local tumor growth with combination therapy indicates that it may be a useful concept in future cancer therapy.

摘要

一种控制肿瘤生长的治疗理念采用了工作日放疗和周末化疗的方式。在小鼠下背部皮下注射P815X2肥大细胞瘤细胞(第0天),并将其分为以下治疗组:每周5天进行X射线照射、单独使用阿霉素,剂量为5mg/kg体重(第6天和第13天)或2mg/kg(第5天、第12天和第19天),以及放疗与化疗联合治疗。未治疗的对照组平均肿瘤体积为2.77cm³,平均生存时间为24天。单独使用5mg/kg阿霉素导致死亡时最终肿瘤体积为对照组的70%,而2mg/kg时肿瘤体积为对照组的60%。仅放疗后,肿瘤大小为对照组的52%。每千克体重照射加5mg或2mg药物导致肿瘤体积分别为对照组的23%和30%。尽管没有治疗方案能延长生存期,但联合治疗使局部肿瘤生长显著减少,这表明它可能是未来癌症治疗中的一个有用理念。

相似文献

1
Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens.采用分次放射治疗与化疗联合方案控制局部肿瘤生长。
J Natl Cancer Inst. 1975 May;54(5):1103-5. doi: 10.1093/jnci/54.5.1103.
2
Treatment of solid P815x2 murine mastocytoma with adriamycin (NSC-1231127): toxity limitations.用阿霉素(NSC-1231127)治疗实体P815x2小鼠肥大细胞瘤:毒性限制
J Natl Cancer Inst. 1976 Mar;56(3):683-5. doi: 10.1093/jnci/56.3.683.
3
Combined-modality oncotherapy with cyclophosphamide (NSC-26271) and radiotherapy: control of murine mastocytoma.环磷酰胺(NSC - 26271)与放疗联合的肿瘤综合治疗:对小鼠肥大细胞瘤的控制
J Natl Cancer Inst. 1976 Oct;57(4):943-9. doi: 10.1093/jnci/57.4.943.
4
Proliferative character and growth modes of neoplastic disease as determinants of chemotherapeutic efficacy.肿瘤疾病的增殖特性和生长模式作为化疗疗效的决定因素。
Cancer Treat Rep. 1976 Dec;60(12):1761-76.
5
A murine Wilms' tumor as a model for chemotherapy and radiotherapy.一种作为化疗和放疗模型的小鼠肾母细胞瘤。
J Natl Cancer Inst. 1976 Jan;56(1):137-42. doi: 10.1093/jnci/56.1.137.
6
Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.实验性实体瘤对辐射的反应:分次照射模式的比较
Br J Cancer. 1975 Feb;31(2):228-36. doi: 10.1038/bjc.1975.29.
7
Urinary excretion of 5-hydroxyindoles as an indicator of in vivo growth of P815X2 mastocytoma.5-羟吲哚的尿排泄作为P815X2肥大细胞瘤体内生长的指标
Eur J Cancer (1965). 1976 Dec;12(12):1011-5. doi: 10.1016/0014-2964(76)90068-2.
8
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.针对同基因DBA/2小鼠体内生长的P815X2肥大细胞瘤的免疫反应。V. 脾脏免疫反应性和细胞介导的细胞毒性。
Arch Geschwulstforsch. 1987;57(4):265-74.
9
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.环磷酰胺-阿霉素联合化疗对可移植性小鼠肿瘤的作用
Cancer Res. 1975 Jun;35(6):1568-73.
10
Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.用于替拉扎明治疗实验性颅内恶性胶质瘤的可植入聚合物
Radiat Oncol Investig. 1999;7(4):218-30. doi: 10.1002/(SICI)1520-6823(1999)7:4<218::AID-ROI3>3.0.CO;2-C.

引用本文的文献

1
Intra-arterial adriamycin chemotherapy for bladder cancer. Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection.动脉内注射阿霉素治疗膀胱癌。注射时采用半选择性动脉内化疗并压迫股动脉。
Cancer Chemother Pharmacol. 1983;11 Suppl:S59-63.
2
The role of preoperative intra-arterial doxorubicin chemotherapy in combination with low-dose irradiation for bladder cancer.术前动脉内阿霉素化疗联合低剂量放疗在膀胱癌治疗中的作用。
Cancer Chemother Pharmacol. 1987;20 Suppl:S10-4. doi: 10.1007/BF00262477.